BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/21/2018 10:07:20 AM | Browse: 910 | Download: 1523
 |
Received |
|
2018-08-10 05:34 |
|
Peer-Review Started |
|
2018-08-10 05:43 |
|
To Make the First Decision |
|
2018-10-24 01:50 |
|
Return for Revision |
|
2018-10-24 08:17 |
|
Revised |
|
2018-11-26 09:17 |
|
Second Decision |
|
2018-12-06 10:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-12-07 03:33 |
|
Articles in Press |
|
2018-12-07 03:33 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-20 08:31 |
|
Publish the Manuscript Online |
|
2018-12-21 10:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Five years of fecal microbiota transplantation - an update of the Israeli experience
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sharon A Greenberg, Ilan Youngster, Nathaniel A Cohen, Dan M Livovsky, Jacob Strahilevitz, Eran Israeli, Ehud Melzer, Kalman Paz, Naomi Fliss-Isakov and Nitsan Maharshak |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nitsan Maharshak, MD, Chief Doctor, Director, Director, Doctor, Doctor, Senior Lecturer, Department of Gastroenterology and Liver Diseases & Bacteriotherapy Clinic, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 6423906, Israel. nitsanm@tlvmc.gov.il |
| Key Words |
Clostridium difficile infection; Capsules; Israel; Fecal microbiota transplantation |
| Core Tip |
Fecal microbiota transplantation (FMT) emerged as a promising treatment for Clostridium difficile infection (CDI). Our aim was to summarize the national Israeli experience in FMT. One-hundred and eleven patients with CDI underwent FMT, 37 (35%) of which via oral capsules and 50 (45%) via colonoscopy. The overall success rate was 87.4%, with no difference between administration routes. Success was independently related to mild disease and an ambulatory setting. One-third of the patients were younger than 60 years. 14 of which (40%) also suffered from inflammatory bowel disease. FMT is an effective treatment for recurrent CDI. FMT via capsules was shown to be a successful alternative to endoscopy. |
| Publish Date |
2018-12-21 10:07 |
| Citation |
Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N. Five years of fecal microbiota transplantation - an update of the Israeli experience. World J Gastroenterol 2018; 24(47): 5403-5414 |
| URL |
https://www.wjgnet.com/1007-9327/full/v24/i47/5403.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v24.i47.5403 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
